Company news
Wuhan YZY Biopharma Co., Ltd. news
Latest news releases, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 4, 2026
Announcement despatch of circular in relation to (1) connected transaction in respect of the proposed issue of new domestic shares under Specific mandate; (2) application for Whitewash Waiver; and (3) proposed amendments to the articles of association
November 3, 2026
Documents on Display
October 30, 2026
Form of proxy for the extraordinary general meeting to be held on Tuesday, 17 November 2026
October 30, 2026
Notice of extraordinary general meeting
October 30, 2026
(1) Connected transaction in respect of the proposed issue of new domestic shares under Specific mandate; (2) application for Whitewash Waiver; (3) proposed amendments to the articles of association; and (4) notice of EGM
October 30, 2026
Closure of register of members for extraordinary general meeting
October 28, 2026
Voluntary announcement the first patient dosed in phase i clinical trial of Y225 for treatment of hemophilia a
October 16, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Delay in despatch of circular in relation to (1) connected transaction in respect of the proposed issue of new domestic shares under Specific mandate; (2) application for Whitewash Waiver; and (3) proposed amendments to the articles of association
September 30, 2026
Update on the qualification of joint company secretary and resignation of joint company secretary and change of process agent
September 30, 2026
2026 Interim report
September 16, 2026
Poll results of the annual general meeting held on Monday, June 29, 2026
June 29, 2026